Triple
T22871194
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | thioridazine |
E567199
|
entity |
| Predicate | actsOnReceptor |
P9769
|
FINISHED |
| Object | dopamine D2 receptor |
—
|
NE NERFINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: dopamine D2 receptor | Statement: [thioridazine, actsOnReceptor, dopamine D2 receptor]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: dopamine D2 receptor Context triple: [thioridazine, actsOnReceptor, dopamine D2 receptor]
-
A.
Dopamine
"Dopamine" is a 2015 studio album by American rock band Third Eye Blind, noted for its alternative rock sound and introspective lyrics.
-
B.
CB2 receptor
The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
-
C.
M2 muscarinic acetylcholine receptor
The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
-
D.
mu-opioid receptor
The mu-opioid receptor is a G protein–coupled receptor in the nervous system that mediates the powerful analgesic and euphoric effects of opioids as well as their major side effects, including respiratory depression and dependence.
-
E.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: dopamine D2 receptor Target entity description: The dopamine D2 receptor is a G protein–coupled receptor in the brain that plays a key role in modulating dopamine signaling, influencing movement, motivation, and many psychiatric and neurological processes.
-
A.
Dopamine
"Dopamine" is a 2015 studio album by American rock band Third Eye Blind, noted for its alternative rock sound and introspective lyrics.
-
B.
CB2 receptor
The CB2 receptor is a cannabinoid receptor primarily expressed in immune and peripheral tissues, where it modulates inflammation and immune responses and serves as a key target of compounds like THC.
-
C.
M2 muscarinic acetylcholine receptor
The M2 muscarinic acetylcholine receptor is a G protein–coupled receptor subtype primarily found in the heart, where it mediates parasympathetic (vagal) effects such as slowing heart rate and reducing contractility.
-
D.
mu-opioid receptor
The mu-opioid receptor is a G protein–coupled receptor in the nervous system that mediates the powerful analgesic and euphoric effects of opioids as well as their major side effects, including respiratory depression and dependence.
-
E.
CB1 receptor
The CB1 receptor is a G protein–coupled cannabinoid receptor in the brain and nervous system that mediates most of the psychoactive effects of cannabis.
- F. None of above. chosen
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e24589d8348190b96422d13a678bc1 |
completed | April 17, 2026, 2:36 p.m. |
| NER | Named-entity recognition | batch_69f17f04b06481909004818ec8fc5a26 |
completed | April 29, 2026, 3:46 a.m. |
Created at: April 17, 2026, 3:38 p.m.